UCB4594
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UCB4594, covering 2024-08-20 to 2024-08-20. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer [Phase 1, Phase 2]